caffeine has been researched along with 2019 Novel Coronavirus Disease in 20 studies
Excerpt | Relevance | Reference |
---|---|---|
" Having the potential role in suppressing inflammation, immune modulation, antiviral and improving respiratory symptoms, this review discusses the potential role of methylxanthine drugs like pentoxifylline and caffeine in the management of COVID-19 patients." | 5.05 | Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic. ( Al-Mahmood Siddiquee, A; Hashemian, F; Monji, F, 2020) |
"Caffeine has been proven to be an effective anti-inflammatory and immunomodulator." | 2.72 | Possible Beneficial Actions of Caffeine in SARS-CoV-2. ( Flores-Soto, E; Montaño, LM; Pérez-Figueroa, GE; Ramírez-Salinas, GL; Romero-Martínez, BS; Solís-Chagoyán, H; Sommer, B, 2021) |
"Increased substance use was reported by 30%, including increased alcohol (13." | 1.91 | COVID-19 Pandemic Responses among National Guard Service Members: Stressors, Coping Strategies, Sleep Difficultiesand Substance Use. ( Fullerton, CS; Mash, HBH; Morganstein, JC; Ursano, RJ, 2023) |
"caffeine and sucrose) was not significant." | 1.72 | Development of a Graphene-Oxide-Deposited Carbon Electrode for the Rapid and Low-Level Detection of Fentanyl and Derivatives. ( Bizzotto, D; Ginoux, E; Jun, D; Rezazadeh-Azar, P; Sammis, G, 2022) |
"Caffeine is a common stimulant consumed daily worldwide and available in a wide variety of over-the-counter formulations." | 1.62 | The importance of early use of beta blockers and gastric decontamination in caffeine overdose: A case report. ( Ajjampur, K; Subramaniam, A, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 20 (100.00) | 2.80 |
Authors | Studies |
---|---|
Caliskan, SG | 1 |
Kilic, MA | 1 |
Bilgin, MD | 1 |
Romdhani, M | 1 |
Rae, DE | 1 |
Nédélec, M | 1 |
Ammar, A | 1 |
Chtourou, H | 1 |
Al Horani, R | 1 |
Ben Saad, H | 1 |
Bragazzi, N | 1 |
Dönmez, G | 1 |
Driss, T | 1 |
Fullagar, HHK | 1 |
Farooq, A | 1 |
Garbarino, S | 1 |
Hammouda, O | 1 |
Hassanmirzaei, B | 1 |
Khalladi, K | 1 |
Khemila, S | 1 |
Mataruna-Dos-Santos, LJ | 1 |
Moussa-Chamari, I | 1 |
Mujika, I | 1 |
Muñoz Helú, H | 1 |
Norouzi Fashkhami, A | 1 |
Paineiras-Domingos, LL | 1 |
Rahbari Khaneghah, M | 1 |
Saita, Y | 1 |
Trabelsi, K | 1 |
Vitale, JA | 1 |
Washif, JA | 1 |
Weber, J | 1 |
Souissi, N | 1 |
Taylor, L | 1 |
Chamari, K | 1 |
Albrecht, JN | 1 |
Werner, H | 1 |
Rieger, N | 1 |
Widmer, N | 1 |
Janisch, D | 1 |
Huber, R | 1 |
Jenni, OG | 1 |
Cafiero, C | 1 |
Micera, A | 1 |
Re, A | 1 |
Schiavone, B | 1 |
Benincasa, G | 1 |
Palmirotta, R | 1 |
Hahn, RZ | 1 |
Bastiani, MF | 1 |
Lizot, LLF | 1 |
Schneider, A | 1 |
da Silva Moreira, IC | 1 |
Meireles, YF | 1 |
Viana, MF | 1 |
do Nascimento, CA | 1 |
Linden, R | 1 |
Bakaloudi, DR | 1 |
Evripidou, K | 1 |
Jayawardena, R | 1 |
Breda, J | 1 |
Dardavessis, T | 1 |
Poulia, KA | 1 |
Chourdakis, M | 1 |
Shaaban, R | 1 |
Ghazy, RM | 1 |
Elsherif, F | 1 |
Ali, N | 1 |
Yakoub, Y | 1 |
Aly, MO | 1 |
ElMakhzangy, R | 1 |
Abdou, MS | 1 |
McKinna, B | 1 |
Elzorkany, AM | 1 |
Abdullah, F | 1 |
Alnagar, A | 1 |
ElTaweel, N | 1 |
Alharthi, M | 1 |
Mohsin, A | 1 |
Ordóñez-Cruickshank, A | 1 |
Toniolo, B | 1 |
Grafolin, T | 1 |
Aye, TT | 1 |
Goh, YZ | 1 |
Deghidy, EA | 1 |
Bahri, S | 1 |
Sappayabanphot, J | 1 |
Elhadi, YAM | 1 |
Mohammed, S | 1 |
El-Deen, AN | 1 |
Ismail, I | 1 |
ElHafeez, SA | 1 |
Elbarazi, I | 1 |
Saddik, B | 1 |
El-Khatib, Z | 1 |
Mohsin, H | 1 |
Kamal, A | 1 |
Ahammed, GJ | 1 |
Li, X | 2 |
Tomsone, LE | 1 |
Perkons, I | 1 |
Sukajeva, V | 1 |
Neilands, R | 1 |
Kokina, K | 1 |
Bartkevics, V | 1 |
Pugajeva, I | 1 |
Hsu, SY | 1 |
Bayati, M | 1 |
Li, C | 1 |
Hsieh, HY | 1 |
Belenchia, A | 1 |
Klutts, J | 1 |
Zemmer, SA | 1 |
Reynolds, M | 1 |
Semkiw, E | 1 |
Johnson, HY | 1 |
Foley, T | 1 |
Wieberg, CG | 1 |
Wenzel, J | 1 |
Johnson, MC | 1 |
Lin, CH | 1 |
Abdool-Ghany, AA | 1 |
Sahwell, PJ | 1 |
Klaus, J | 1 |
Gidley, ML | 1 |
Sinigalliano, CD | 1 |
Solo-Gabriele, HM | 1 |
Jun, D | 1 |
Sammis, G | 1 |
Rezazadeh-Azar, P | 1 |
Ginoux, E | 1 |
Bizzotto, D | 1 |
Cipriani-Avila, I | 1 |
Molinero, J | 1 |
Cabrera, M | 1 |
Medina-Villamizar, EJ | 1 |
Capparelli, MV | 1 |
Jara-Negrete, E | 1 |
Pinos-Velez, V | 1 |
Acosta, S | 1 |
Andrade, DL | 1 |
Barrado, M | 1 |
Mogollón, NGS | 1 |
Parisi, L | 1 |
Mulargia, S | 1 |
Comunello, F | 1 |
Bernardini, V | 1 |
Bussoletti, A | 1 |
Nisi, CR | 1 |
Russo, L | 1 |
Campagna, I | 1 |
Lanfranchi, B | 1 |
Croci, I | 1 |
Grassucci, E | 1 |
Gesualdo, F | 1 |
Mash, HBH | 1 |
Morganstein, JC | 1 |
Fullerton, CS | 1 |
Ursano, RJ | 1 |
Monji, F | 1 |
Al-Mahmood Siddiquee, A | 1 |
Hashemian, F | 1 |
Ajjampur, K | 1 |
Subramaniam, A | 1 |
Liu, L | 1 |
Zhang, C | 1 |
Chen, J | 1 |
Mattioli, AV | 1 |
Farinetti, A | 1 |
Romero-Martínez, BS | 1 |
Montaño, LM | 1 |
Solís-Chagoyán, H | 1 |
Sommer, B | 1 |
Ramírez-Salinas, GL | 1 |
Pérez-Figueroa, GE | 1 |
Flores-Soto, E | 1 |
4 reviews available for caffeine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
The Impact of Lockdowns on Caffeine Consumption: A Systematic Review of the Evidence.
Topics: Caffeine; Coffee; Communicable Disease Control; COVID-19; Energy Drinks; Female; Humans; Middle Aged | 2022 |
Hormonal regulation of health-promoting compounds in tea (Camellia sinensis L.).
Topics: Anthocyanins; Caffeine; Camellia sinensis; Catechin; COVID-19; Humans; Plant Leaves; Polyphenols; SA | 2022 |
Can pentoxifylline and similar xanthine derivatives find a niche in COVID-19 therapeutic strategies? A ray of hope in the midst of the pandemic.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Caffeine; Coronavirus Infections; COVID-19; COVID-19 Drug T | 2020 |
Possible Beneficial Actions of Caffeine in SARS-CoV-2.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Caffeine; COVID-19; Drug Repositioning; Humans; Immunolo | 2021 |
16 other studies available for caffeine and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Reply to "Changes in energy drink consumption during the COVID-19 quarantine".
Topics: Caffeine; COVID-19; Energy Drinks; Humans; Quarantine; SARS-CoV-2 | 2021 |
COVID-19 Lockdowns: A Worldwide Survey of Circadian Rhythms and Sleep Quality in 3911 Athletes from 49 Countries, with Data-Driven Recommendations.
Topics: Adolescent; Adult; Athletes; Caffeine; Circadian Rhythm; Communicable Disease Control; COVID-19; Cro | 2022 |
Association Between Homeschooling and Adolescent Sleep Duration and Health During COVID-19 Pandemic High School Closures.
Topics: Adolescent; Adolescent Health; Caffeine; Communicable Disease Control; COVID-19; Cross-Sectional Stu | 2022 |
Comment on Kopańska et al. Disorders of the Cholinergic System in COVID-19 Era-A Review of the Latest Research.
Topics: Acetylcholine; Acetylcholinesterase; Antiviral Agents; Caffeine; COVID-19; Cytokine Release Syndrome | 2022 |
Long-term monitoring of drug consumption patterns during the COVID-19 pandemic in a small-sized community in Brazil through wastewater-based epidemiology.
Topics: Amphetamine; Brazil; Caffeine; Cocaine; COVID-19; Dronabinol; Humans; Illicit Drugs; N-Methyl-3,4-me | 2022 |
COVID-19 Vaccine Acceptance among Social Media Users: A Content Analysis, Multi-Continent Study.
Topics: Caffeine; COVID-19; COVID-19 Vaccines; Humans; Morocco; Social Media; Thailand; Vaccination; Vaccine | 2022 |
Consumption trends of pharmaceuticals and psychoactive drugs in Latvia determined by the analysis of wastewater.
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Caffeine; COVID-19; Ethanol; Humans; Latvia; Nicotin | 2022 |
Biomarkers selection for population normalization in SARS-CoV-2 wastewater-based epidemiology.
Topics: Biomarkers; Caffeine; COVID-19; Creatinine; Humans; Hydroxyindoleacetic Acid; RNA, Viral; SARS-CoV-2 | 2022 |
Fecal indicator bacteria levels at a marine beach before, during, and after the COVID-19 shutdown period and associations with decomposing seaweed and human presence.
Topics: Acetaminophen; Animals; Bacteria; Bathing Beaches; Caffeine; COVID-19; Dogs; Enterococcus; Environme | 2022 |
Development of a Graphene-Oxide-Deposited Carbon Electrode for the Rapid and Low-Level Detection of Fentanyl and Derivatives.
Topics: Analgesics, Opioid; Caffeine; Carbon; Cocaine; COVID-19; Electrodes; Fentanyl; Graphite; Heroin; Hum | 2022 |
Occurrence of emerging contaminants in surface water bodies of a coastal province in Ecuador and possible influence of tourism decline caused by COVID-19 lockdown.
Topics: Caffeine; Communicable Disease Control; COVID-19; Diclofenac; Ecosystem; Ecuador; Environmental Moni | 2023 |
Exploring the vaccine conversation on TikTok in Italy: beyond classic vaccine stances.
Topics: Caffeine; Communication; COVID-19; Female; Humans; Italy; Pandemics; Social Media; Vaccines | 2023 |
COVID-19 Pandemic Responses among National Guard Service Members: Stressors, Coping Strategies, Sleep Difficultiesand Substance Use.
Topics: Adaptation, Psychological; Caffeine; COVID-19; Female; Humans; Male; Pandemics; Sleep Initiation and | 2023 |
The importance of early use of beta blockers and gastric decontamination in caffeine overdose: A case report.
Topics: Adrenergic beta-Antagonists; Caffeine; COVID-19; Drug Overdose; Female; Gastric Lavage; Humans; Midd | 2021 |
Rediscovery of Caffeine: An Excellent Drug for Improving Patient Outcomes while Fighting WARS.
Topics: Caffeine; COVID-19; Humans; Pandemics; Pharmaceutical Preparations; SARS-CoV-2 | 2021 |
Energy drinks and medical students: Bad drinking during COVID-19 quarantine.
Topics: Caffeine; COVID-19; Energy Drinks; Humans; Quarantine; SARS-CoV-2; Students, Medical; Surveys and Qu | 2021 |